stella
beta
Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer — Stella
Recruiting
Back to Differentiated Thyroid Cancer trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(5 sites)
United States
University of California, San Francisco, San Francisco, California
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania
St. Jude Children's Research Hospital, Memphis, Tennessee
MD Anderson Cancer Center, Houston, Texas
Seattle Children's Hospital, Seattle, Washington
View full record on ClinicalTrials.gov